Inspired by patients. Driven by science.
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients.
Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?”
And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.
UCB – The Facts
With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs.
A few other reasons that make UCB an amazing place to work:
- Promising pipeline that includes several novel molecules;
- 2023 Key Financials: € 5.3 billion global revenue
Specialties: Neurology, Immunology
Neurology, Immunology, and Healthcare Innovation Beyond Medicine
Home | UCB
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Sorcero healthtech, Software Development | Other 9 May 2024 | | ||
Carenity healthtech, Research Services | Other 21 Apr 2024 | | ||
AXELIFE manufacturing, deeptech, healthtech, Medical Equipment Manufacturing | Other 30 Apr 2024 | | ||
essenscia Chemical Manufacturing | Other 27 Apr 2024 | | ||
Life Plus IO healthtech, silvertech, Wellness and Fitness Services | Other 24 Apr 2024 | | ||
Nerdio it services, Software Development | Other 23 Apr 2024 | | ||
assar constructiontech, smart city, Architecture and Planning | Other 27 Mar 2024 | | ||
ExeVir biotech, deeptech, Biotechnology Research | Other 29 Feb 2024 | | ||
Axylia Investment Banking | Other 30 Mar 2024 | | ||
Institut de la Mère et de l'Enfant healthtech | Other 28 Mar 2024 | |